新闻中心
News Center
2019-Fangu Public Welfare- "Donate Winter Clothes, Send Warmth" Charity Public Welfare Activity
Release Time
2022-06-21 16:12
|
In order to send warmth to people in poverty-stricken areas, on November 29, the company launched the "donate winter clothes, send warmth" charity activity. After the event was released, colleagues from various departments actively participated and actively donated clothes. As of December 13, 8 boxes of clothes were received after sorting out by members of the company's love team. On the same day, this batch of clothes was sent to Guiping, Guangxi, hoping to bring some warmth to those in need in the cold winter.
  |
Related News
Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.
2022-05-25
On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.
2022-05-25
Foncoo Pharmaceutical's corporate culture 5.0 was officially released
Official announcement! Seriously, don't be distracted!
2022-05-25
On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.
2022-05-25
Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.
2022-05-25
Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum
From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".
2022-05-25
Contact Us：
Room 1502-1506, Building D2, Nanshan iPark, No.1001 Xue Yuan Boulevard, Nanshan District, Shenzhen, China.
Follow Us
© COPYRIGHT 2021 Shenzhen Foncoo Pharmaceutical Co., Ltd. ALL RIGHTS RESERVED